October 14, 2009 – Medtronic Inc. yesterday initiated a feasibility study of an interventional treatment for ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
October 6, 2009 – The Harvard Clinical Research Institute (HCRI) said last week the first patients are enrolled ...
October 06, 2009
October 6, 2009 - Boston Scientific Corp. announced it has received 510(k) clearance from the U.S. Food and Drug ...
October 06, 2009Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a ...
October 06, 2009
October 5, 2009 – In a breakthrough development that could dramatically reduce the number of leg amputations and ...
October 10, 2011
October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational ...
October 01, 2009
October 1, 2009 – The six-month clinical outcome of Sahajanand Medical Technologies Supralimus Sirolimus-Eluting ...
October 01, 2009
September 30, 2009 – Invatec this week at the European CIRSE 2009 conference launched its latest self-expanding ...
September 30, 2009
September 30, 2009 – New clinical data released at TCT 2009 last week showed strong and sustained efficacy and ...
September 30, 2009
September 29, 2009 – Among the biggest news to come out of TCT 2009 last week was the late-breaking data from the ...
September 30, 2009September 29, 2009 – Cordis Corp. and Boston Scientific announced late today they reached an agreement to resolve ...
September 29, 2009September 29, 2009 – Elixir Medical Corp. last week at TCT 2009 announced positive results from three multicenter ...
September 29, 2009September 29, 2009 – Boston Scientific Corp. Sept. 25 announced two-year follow-up data from the HORIZONS-AMI ...
September 29, 2009
September 29, 2009 – At six months, patients receiving the NEVO Sirolimus-Eluting Coronary Stent reported ...
September 29, 2009September 21, 2009 — Boston Scientific Corp. today welcomed three-year results from the SPIRIT III clinical trial ...
September 22, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now